Disphanurat, Wareeporn, and Benjaporn Srisantithum. “Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined With Hyaluronic Acid Versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A Randomized Evaluator-Blind Trial”. Asian Medical Journal and Alternative Medicine 22, no. - (August 1, 2022): S117. Accessed April 20, 2024. https://asianmedjam.com/index.php/amjam/article/view/1287.